Capricor Therapeutics
CAPR
#5678
Rank
ยฃ1.01 B
Marketcap
ยฃ17.59
Share price
-3.10%
Change (1 day)
143.51%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -ยฃ78.43 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -ยฃ30.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -ยฃ79.19 Million159.57%
2024 -ยฃ30.51 Million81.57%
2023 -ยฃ16.81 Million-23.2%
2022 -ยฃ21.88 Million44.93%
2021 -ยฃ15.1 Million46.61%
2020 -ยฃ10.3 Million78.71%
2019 -ยฃ5.77 Million-49.7%
2018 -ยฃ11.46 Million-724.78%
2017 ยฃ1.83 M-112.93%
2016 -ยฃ14.18 Million46.27%
2015 -ยฃ9.7 Million106.82%
2014 -ยฃ4.69 Million-48.41%
2013 -ยฃ9.09 Million977.23%
2012 -ยฃ0.85 Million-77.11%
2011 -ยฃ3.69 Million-22.35%
2010 -ยฃ4.75 Million-20.17%
2009 -ยฃ5.95 Million-41.17%
2008 -ยฃ10.11 Million41.05%
2007 -ยฃ7.17 Million1098.87%
2006 -ยฃ0.6 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.58 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.60 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.63 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.22 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.62 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.16 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA